Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Spider-Man vitamins

This article was originally published in The Tan Sheet

Executive Summary

Children's chewable multivitamins featuring the web-slinging superhero shipping in March, Tampa, Fla.-based TrimFast Group says. TV ads are planned for Saturday morning Spider-Man cartoons on Fox and WB networks, with a deal in the works for print ads in New York-based Marvel Comics magazines. Increased ad spend, potential merchandising to be timed with first of three motion pictures premiering Spring 2002. Sixty-count bottles shaped like Spidey's head will sell for $9.95 at food, drug and mass outlets and on the Sci-Fi Network's Web site. TrimFast and Marvel signed a licensing deal last year (1"The Tan Sheet" Jan. 10, 2000, In Brief)

Children's chewable multivitamins featuring the web-slinging superhero shipping in March, Tampa, Fla.-based TrimFast Group says. TV ads are planned for Saturday morning Spider-Man cartoons on Fox and WB networks, with a deal in the works for print ads in New York-based Marvel Comics magazines. Increased ad spend, potential merchandising to be timed with first of three motion pictures premiering Spring 2002. Sixty-count bottles shaped like Spidey's head will sell for $9.95 at food, drug and mass outlets and on the Sci-Fi Network's Web site. TrimFast and Marvel signed a licensing deal last year (1 (Also see "Trimfast Group" - Pink Sheet, 10 Jan, 2000.)).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092133

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel